Results 221 to 230 of about 3,756,307 (284)
Line-of-Sight Probability Analysis of Underground Mining Visible Light Communication Diversity Schemes Under Random Receiver Orientation. [PDF]
Solís J +5 more
europepmc +1 more source
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang +3 more
wiley +1 more source
The influence of shot noise on the performance of phase singularity-based refractometric sensors. [PDF]
Maslova V +5 more
europepmc +1 more source
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee +8 more
wiley +1 more source
Impact of spatial lesion symmetry on the structural response of hydroxylated B-DNA. [PDF]
Noohi B, Zahedi M.
europepmc +1 more source
Tumor mutational burden as a determinant of metastatic dissemination patterns
This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal +4 more
wiley +1 more source
Inhomogeneous broadening in the time domain: Gauss-Lorentz, Gauss-Drude and Gauss-Debye material models. [PDF]
Prokopeva LJ, Kildishev AV.
europepmc +1 more source
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source
Positivity-Preserving Hybridizable Discontinuous Galerkin Scheme for Solving PNP Model. [PDF]
Morales D, Xu Z.
europepmc +1 more source

